Novartis’ Cholesterol Drug Inclisiran Closes In On EU Approval
Drug Will Be Known As Leqvio
Timing means full EU approval could coincide with US FDA authorization later this year.
You may also be interested in...
Many clinicians doubt that aducanumab can really help slow the decline in Alzheimer’s patients – but US FDA could offer it the benefit of the doubt.
Vertex has become a biotech investor favorite amid the tumult of 2020, but the potential of its pipeline is now under question.
Analysts are confident that Pfizer/BioNTech’s mRNA vaccine will prove its safety and efficacy – but waiting a little longer for more robust data could be for the best.